This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Kaohsiung Medical University. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Ming-Ying Lu
Introduction
Ming-Ying Lu is a notable inventor based in Magong, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of chronic hepatitis C. His innovative approach has led to the development of a method that enhances the efficacy of treatment protocols.
Latest Patents
Ming-Ying Lu holds a patent for a method titled "Method for predicting treatment efficacy of peginterferon plus ribavirin treatment in a subject suffering from hepatitis C." This invention provides a systematic approach to predicting treatment outcomes by measuring gene expression levels in patients. The method involves analyzing specific genes in a blood sample after one week of treatment and calculating a gene score to determine the likelihood of successful treatment.
Career Highlights
Ming-Ying Lu is affiliated with Kaohsiung Medical University, where he continues to engage in research and development in the medical field. His work has been instrumental in advancing treatment methodologies for hepatitis C, showcasing his commitment to improving patient outcomes.
Collaborations
Ming-Ying Lu has collaborated with esteemed colleagues such as Chia-Yen Dai and Jee-Fu Huang. Their combined expertise has contributed to the success of their research initiatives and the development of innovative treatment methods.
Conclusion
Ming-Ying Lu's contributions to medical science, particularly in hepatitis C treatment, highlight his role as an influential inventor. His patented method represents a significant advancement in predicting treatment efficacy, ultimately benefiting patients worldwide.